Cite

HARVARD Citation

    Campochiaro, C. et al. (2022). Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy. Scandinavian journal of rheumatology. pp. 243-245. [Online]. 
  
Back to record